News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
240,924 Results
Type
Article (6296)
Company Profile (23)
Press Release (234605)
Section
Business (87443)
Career Advice (467)
Deals (16397)
Drug Delivery (8)
Drug Development (21410)
Employer Resources (30)
FDA (4337)
Job Trends (4300)
News (130320)
Policy (8652)
Tag
Academia (304)
Alliances (16385)
Alzheimer's disease (221)
Approvals (4336)
Bankruptcy (101)
Best Places to Work (3034)
Biotechnology (25)
Breast cancer (22)
Cancer (260)
Career advice (396)
Cell therapy (56)
Clinical research (17738)
Collaboration (93)
Compensation (70)
COVID-19 (314)
C-suite (48)
Data (323)
Diabetes (29)
Diagnostics (2088)
Earnings (41875)
Employer resources (31)
Events (38936)
Executive appointments (144)
FDA (4458)
Funding (98)
Gene therapy (27)
GLP-1 (106)
Government (445)
Healthcare (5200)
Infectious disease (327)
Inflammatory bowel disease (23)
Interviews (53)
IPO (8063)
Job creations (1342)
Job search strategy (365)
Layoffs (104)
Legal (2722)
Lung cancer (28)
Manufacturing (30)
Medical device (4056)
Medtech (4057)
Mergers & acquisitions (8379)
Metabolic disorders (82)
Neuroscience (271)
NextGen Class of 2024 (1725)
Non-profit (740)
Northern California (546)
Obesity (39)
Opinion (29)
People (25629)
Phase I (5130)
Phase II (7563)
Phase III (6276)
Pipeline (273)
Postmarket research (834)
Preclinical (1971)
Press Release (66)
Radiopharmaceuticals (105)
Rare diseases (39)
Real estate (2003)
Regulatory (5718)
Research institute (325)
Resumes & cover letters (68)
Southern California (409)
Startups (1097)
United States (4371)
Vaccines (31)
Date
Today (14)
Last 7 days (182)
Last 30 days (1305)
Last 365 days (11826)
2024 (10945)
2023 (13929)
2022 (20385)
2021 (21247)
2020 (19730)
2019 (14249)
2018 (11009)
2017 (11221)
2016 (10365)
2015 (13654)
2014 (10706)
2013 (8455)
2012 (9082)
2011 (9476)
2010 (9338)
Location
Africa (193)
Arizona (49)
Asia (11923)
Australia (1647)
California (1102)
Canada (465)
China (31)
Colorado (43)
Connecticut (56)
Europe (35134)
Florida (141)
Idaho (23)
Illinois (81)
Indiana (37)
Japan (31)
Kansas (24)
Maine (34)
Maryland (147)
Massachusetts (947)
Michigan (60)
Minnesota (99)
New Jersey (339)
New York (306)
North Carolina (261)
Northern California (546)
Ohio (36)
Pennsylvania (242)
South America (300)
Southern California (409)
Texas (129)
Utah (32)
Virginia (26)
Washington State (101)
240,924 Results for "amarin corporation plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Amarin Board of Directors Announces CEO Transition
Amarin Corporation plc today announced that the Company’s Board of Directors has appointed Aaron Berg, currently Amarin’s Executive Vice President and President of the U.S. Business, as President and Chief Executive Officer (CEO).
June 4, 2024
·
5 min read
Pharm Country
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Amarin Corporation plc (NASDAQ: AMRN) today announced that Patrick Holt, Amarin’s president and chief executive officer, is scheduled to participate in fireside chat at the 2024 H.C. Wainwright 2nd Annual BioConnect Investor Conference.
May 6, 2024
·
2 min read
Pharm Country
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.
Amarin Corporation plc (NASDAQ:AMRN) today announces that the Greek Ministry of Health has approved VAZKEPA.
May 28, 2024
·
6 min read
Pharm Country
Amarin Announces Results of Annual General Meeting of Shareholders
Amarin Corporation plc announced shareholder approval of all proposed resolutions specified at its 2024 Annual General Meeting.
April 22, 2024
·
5 min read
Business
Amarin Reports First Quarter 2024 Business Update and Financial Results
Amarin Corporation plc, provided an update on the Company’s business highlights and announced financial results for the quarter ended March 31, 2024.
May 1, 2024
·
19 min read
Business
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Patrick Holt, President & CEO, and members of Amarin’s senior management team to discuss its first quarter 2024 results followed by Q&A on Wednesday, May 1st , 2024, at 8:00 a.m. ET.
April 15, 2024
·
2 min read
Pharm Country
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
Amarin Corporation plc highlighted three data presentations at ACC.24 showcasing the mechanistic activity of Eicosapentaenoic acid, including the potential effects of EPA on endothelial cell dysfunction and on oxidation of samples enriched with Lp.
April 8, 2024
·
12 min read
Pharm Country
Amarin Chairman & CEO Issue Letter to Shareholders - Jan 22, 2024
Amarin Corporation plc announced that the Company’s Chairman of the Board, Odysseas Kostas, M.D., and President & CEO, Patrick Holt, issued the following letter to Amarin shareholders.
January 22, 2024
·
5 min read
Business
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Amarin Corporation plc, announced financial results for the quarter and year ended December 31, 2023 and provided an update on the Company’s operations.
February 29, 2024
·
17 min read
Business
Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024
Amarin Corporation plc announced that it will host a conference call with Patrick Holt, President & CEO, and members of Amarin’s senior management team to discuss its fourth quarter and year end 2023 results on Thursday, February 29th, 2024, at 8:00 a.m. ET.
February 15, 2024
·
2 min read
1 of 24,093
Next
